2008
DOI: 10.1001/archfaci.10.2.84
|View full text |Cite
|
Sign up to set email alerts
|

Botulinum Toxin and Quality of Life in Patients With Facial Paralysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
64
0
5

Year Published

2011
2011
2015
2015

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 86 publications
(70 citation statements)
references
References 23 publications
1
64
0
5
Order By: Relevance
“…It has been used extensively in the literature to report QOL improvement after a variety of treatment modalities in patients with both flaccid paralysis and NFFP. 7,8,14,19 A recent systematic review of patient-reported outcome measures determined that the FaCE scale was 1 of only 3 questionnaires among the 28 questionnaires reviewed that satisfied the authors' inclusion and exclusion criteria. 9 The authors concluded that the FaCE scale extensively covered both physical and social functioning but was limited by the use of classical test theory, which assumes that all items contribute equally to the final score.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been used extensively in the literature to report QOL improvement after a variety of treatment modalities in patients with both flaccid paralysis and NFFP. 7,8,14,19 A recent systematic review of patient-reported outcome measures determined that the FaCE scale was 1 of only 3 questionnaires among the 28 questionnaires reviewed that satisfied the authors' inclusion and exclusion criteria. 9 The authors concluded that the FaCE scale extensively covered both physical and social functioning but was limited by the use of classical test theory, which assumes that all items contribute equally to the final score.…”
Section: Discussionmentioning
confidence: 99%
“…The Facial Clinimetric Evaluation (FaCE) scale is a validated patient-based instrument designed to measure facial impairment and disability, and it permits clinicians to effectively analyze disease-specific quality of life (QOL). 6 The instrument has been used in previous research to show the adverse consequences of synkinesis 7 and the benefits of periocular surgery on QOL. 8 A recent systematic review of patient-reported outcome measures for facial paralysis reported that the FaCE scale is 1 of only 3 questionnaires that satisfied the authors' inclusion criteria.…”
mentioning
confidence: 99%
“…These results quantify the physical effect of Botulinum toxin, which other authors have previously shown to result in an improvement in patients' quality of life. 5 This quantification will be useful if comparisons of the efficacy of different Botulinum toxin preparations were to be made. However, a limitation of this method is that it is specific for quantifying oral-ocular synkinesis and cannot in its present form be used to quantify other types of facial synkinesis.…”
Section: Discussionmentioning
confidence: 99%
“…Synkinesis, therefore, frequently has a negative effect on a patient's quality of life. 4,5 Since the early 1990s, directed Botulinum toxin injection to affected muscles has been the mainstay of treatment of synkinetic movement disorders. 6,7 The Botulinum toxin inhibits the release of acetylcholine from the presynaptic nerve terminal at the neuromuscular junction, preventing the propagation of the action potential and contraction of the targeted muscle.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation